Skip to main content

2023 ERS Congress

European Respiratory Society (ERS) 2023: In-depth report

This in-depth report provides an overview of the latest advances in the diagnosis, treatment and management of chronic obstructive pulmonary disease and interstitial lung disease presented at ERS 2023.

Supported by:
  • F. Hoffmann-La Roche Ltd.
Developed by: Springer Healthcare
Access the report

Automatic oxygen delivery leads to better control but not earlier discharge

COPD patients who are automatically administered oxygen during hospitalization for exacerbation spend more time in normoxemia than patients in whom oxygen delivery is manually regulated.

Cardiac MRI for risk stratification of PAH

A new risk stratification approach allows physicians to estimate 1-year mortality for newly diagnosed patients with pulmonary arterial hypertension based on cardiac MRI.

Sputum colour for prediction of bronchiectasis prognosis

Sputum colour in patients with bronchiectasis could be considered a simple biomarker, providing information about long-term prognosis.

Breath test distinguishes people with and without asthma

A deep neural network has been developed to distinguish between patients with and without asthma through breath test measurement data.

Inhaled idrevloride in hypertonic saline may benefit patients with primary ciliary dyskinesia

People with primary ciliary dyskinesia may show improved lung function after treatment with inhaled idrevloride in hypertonic saline.

Read more

Benralizumab may still lead to remission even in second year of treatment

Up to a third of patients with severe eosinophilic asthma who do not achieve clinical remission after 1 year of treatment with benralizumab still achieve remission in the second year.

Effect of the infant microbiome on wheezing at preschool age

Results from the Australian Barwon Infant Study show children who have a more mature gastrointestinal microbiome at age 1 are less likely to suffer from atopic wheeze at age 4.

Smoking cessation program integrated with lung cancer screening

A stop-smoking intervention, offered in combination with a lung cancer screening program, is proving successful in encouraging people to quit smoking.

Triple therapy beneficial for COPD patients with ECG abnormalities

COPD patients with ECG abnormalities are at greater risk of exacerbations, cardiovascular problems, and death. Triple therapy with fluticasone, umeclidinium, and vilanterol appears beneficial.

Pulmonary rehabilitation does not improve BLVR-EBV outcomes

Pulmonary rehabilitation offers no benefit in outcomes for patients already undergoing bronchoscopic lung volume reduction using endobronchial valves.

Feasibility of local care for pulmonary fibrosis patients

Cooperation between local hospitals and specialized centers leads to better care for patients with pulmonary fibrosis, is less environmentally damaging.

Tacrolimus superior to ciclosporin for reducing chronic lung allograft dysfunction

ScanCLAD study findings support the use of once-per-day tacrolimus over twice daily ciclosporin for immunosuppression after lung transplantation.

Read more

Stay up to date with more from Springer Medicine

At a glance: The CheckMate lung cancer trials

A round-up of the CheckMate trials evaluating the PD-1 inhibitor nivolumab in non-small-cell lung cancer and small-cell lung cancer.

Developed by: Springer Medicine

Biomarker-driven management of NSCLC (Link opens in a new window)

Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.

1.0 AMA PRA Category 1 Credit(s)™

Supported by:
  • Bayer HealthCare Pharmaceuticals Inc.
Developed by: Springer Healthcare IME

Further Reading

Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms

Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-MPNs) are a group of malignant clonal disorders originating from bone marrow hematopoietic stem cells, and pulmonary hypertension (PH) is a serious progressive disease often …

Exploring the role of gut microbiota in intervertebral disc degeneration: insights from bidirectional Mendelian randomization analysis

The increasing proportion of elderly individuals, combined with changes in work nature and lifestyle, has led to a significant rise in the incidence of low back pain (LBP) [ 1 ]. This has become a major public health challenge, impacting global …

Transient colonization with Blastocystis spp. after transmission via fecal microbiota transplantation

Fecal microbiota transplantation (FMT) is highly effective for treating recurrent infections with Clostridioides difficile (CDI) [ 1 , 2 ]. In the last decades this therapy has been a popular subject of study for many other indications [ 3 ] …

Intestinal failure from thymoma-associated autoimmune enteropathy: a rare case report

We describe a case of altered bowel habit, early satiety, anorexia and weight loss caused by autoimmune enteropathy. This diagnosis was confirmed by biopsies obtained from upper gastrointestinal endoscopy and ileocolonoscopy. Further …